All Journals

Disseminates rigorous, original scholarship across the full spectrum of diabetology, from the molecular pathophysiology of type 2 diabetes mellitus, insulin resistance and beta-cell dysfunction to the clinical management of glycemic control, diabetic complications and metabolic disease. The journal welcomes work on prediabetes and incident diabetes, risk-factor epidemiology, diabetes prevention and screening, oral hypoglycemic agents and GLP-1 receptor agonists, diabetic nephropathy and chronic kidney disease, genome-wide association and polygenic studies, drug utilization evaluation, and health-related quality of life. We publish original research, systematic and narrative reviews, clinical case reports, and editorials that bridge bench, bedside and population health. JODR serves endocrinologists, diabetologists, nephrologists, clinical researchers, public-health scientists, pharmacologists and trainees seeking a trusted, internationally accessible venue. Every submission undergoes double-blind peer review by subject experts. The journal follows COPE ethical principles, and article-processing charges apply on acceptance with waivers and discounts available.

Dedicated to disseminating original research across tumor biology, cancer diagnostics, and therapeutics. The journal serves as an internationally accessible platform connecting basic scientists, translational researchers, and clinical oncologists working to understand and treat human cancers. We publish work spanning molecular and cellular oncology, the tumor microenvironment, cancer biomarkers and risk stratification, genomic alterations (including p53, RAD51B, and HER2-driven tumors), and emerging therapeutics such as PARP inhibitors, anti-angiogenic and anti-mitotic agents, and drug-repurposing strategies. Clinically oriented subfields include urologic oncology (prostate and bladder cancer, hematuria, cystoscopy), gastrointestinal and colorectal cancer, gynecologic and peritoneal malignancies managed with cytoreductive surgery and HIPEC, head and neck squamous cell carcinoma, and AIDS-defining cancers. The journal welcomes original research, systematic and narrative reviews, case reports, methodological studies, and editorials. Submissions are evaluated through rigorous double-blind peer review to ensure scientific integrity and methodological soundness. All accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright.

Its largest group of papers so far deals with aesthetic and regenerative treatment: collagen biostimulators such as poly-L-lactic acid, calcium hydroxyapatite and polycaprolactone, facial fat grafting (lipofilling) and autologous mesenchymal stem cells for female pattern hair loss. AODS also publishes work on skin cancer surgery, such as frozen section margin control for facial basal cell carcinoma and skin grafts for rebuilding the ear after non-melanoma skin cancer, and on fungal and mycobacterial infections, including chromoblastomycosis. Other papers study moisturisers and topical preparations, from a multicentre study of moisturiser prescribing in Indian dermatology clinics to the stabilisation of aloe vera gel, and the anatomy of the lips and the mucocutaneous junction. The journal welcomes original clinical and laboratory studies, systematic and narrative reviews, and case reports on the skin, hair, nails and adjoining mucosa. Manuscripts are reviewed double-blind, and articles are released under a CC BY 4.0 licence, with copyright kept by the authors. Suspected misconduct, altered clinical images and undeclared conflicts of interest are handled under COPE guidance.

Dedicated to the full spectrum of reconstructive, aesthetic, microsurgical and regenerative surgery. The journal publishes rigorous original research, systematic reviews, technique articles, case reports and editorials that advance clinical practice and translational science across the discipline. The scope spans breast reconstruction and free-flap surgery (including DIEP flaps, microsurgical anastomosis, free-flap monitoring and drain management), craniofacial, maxillofacial and orthognathic surgery, hand surgery and replantation, burn and wound reconstruction, cutaneous tumor and skin lesion management, and aesthetic surgery. We particularly welcome work on regenerative techniques such as adipose-derived mesenchymal stem cells, fat grafting, biomaterials and targeted drug delivery, alongside studies of patient-reported outcomes, quality of life and psychosocial impact. Intended for plastic and reconstructive surgeons, microsurgeons, surgical trainees, and translational researchers, the journal connects bench and bedside through an internationally accessible platform. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. Editorial practice follows COPE principles.

Disseminates rigorous, original scholarship across musculoskeletal, neurological, cardiorespiratory and sports physiotherapy, advancing evidence-based practice for clinicians, researchers, educators and students in physical therapy and rehabilitation science worldwide. The journal welcomes original research articles, randomised controlled trials, systematic reviews and meta-analyses, clinical case reports, technical notes and editorials. Core topics include therapeutic and exercise therapy, manual therapy, low back and neck pain management, post-surgical and orthopaedic rehabilitation, neurological rehabilitation after stroke and spinal cord injury, pain science, posture and movement, telerehabilitation, and validated outcome measures such as disability indices and pressure pain thresholds. JOPTR serves physiotherapists, rehabilitation scientists, exercise physiologists and allied health professionals seeking robust, reproducible findings that bridge laboratory, clinic and community settings. Methodologically diverse quantitative and qualitative work is encouraged, with transparent reporting and clinically meaningful outcomes prioritised. Every submission undergoes double-blind peer review. Accepted articles are published under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. The journal follows COPE ethical principles.

Its published work so far centres on cancer screening and access to cancer care, vaccine confidence and antiviral research, maternal and child health and nutrition, cardiovascular risk in defined populations, antibiotic prescribing and adherence, and health systems and policy. TAJOPH publishes original studies, systematic, narrative and mini-reviews, and policy perspectives. Recent examples include a review of breast cancer screening among immigrant women in the United States, a prospective cohort evaluation of a pilot community-based programme for acute malnutrition in Central India, an analysis of cardiovascular risk factors by age in African Americans from the Jackson Heart Study, and a study of how diagnostic uncertainty shapes antibiotic prescribing by primary-care doctors in Lubumbashi. Cross-sectional surveys, cohort studies and programme evaluations from any country are welcome. Referees assess TAJOPH submissions double-blind, after an initial screening by the editors. Published TAJOPH papers carry the CC BY 4.0 licence and their authors keep the copyright, and the journal follows the COPE guidelines when it handles questions of publication ethics. There is no charge until a paper is accepted; unfunded authors may then request a need-based waiver or discount.

Its published articles so far come mainly from gynecologic oncology and pathology and from high-risk pregnancy and obstetric complications, with smaller groups in early and ectopic pregnancy, infertility and reproductive endocrinology, urogynecology and pelvic floor disorders, and surgery and perioperative care in obstetrics and gynecology. JOCOGR publishes original clinical studies, systematic reviews and case reports. Recent examples include a study of feeding time after caesarean section, an evaluation of serum pentraxin 3 for predicting gestational diabetes, a pathology study of high-grade ovarian cancers that arise with seromucinous borderline tumors, and a case of postpartum RCVS–PRES first mistaken for post-dural puncture headache. The journal suits obstetricians, gynecologists, fertility and pelvic-floor specialists and gynecologic pathologists who want to report what they see in practice, from a single unusual case to a hospital cohort. Each manuscript goes through double-blind peer review before an editor decides on it. Accepted papers appear open access under a CC BY 4.0 licence, and copyright in each one stays with its authors. Directive Publications follows COPE ethical principles. An article-processing charge applies on acceptance, with waivers and discounts available to support equitable participation. Researchers and clinicians worldwide are invited to read JOCOGR and to submit their manuscripts.

We publish original research, clinical case reports and case series, systematic and narrative reviews, and editorials spanning neonatology and neonatal intensive care, general and community pediatrics, pediatric rheumatology and autoimmunity (including juvenile idiopathic arthritis), pediatric oncology and hematology, pediatric infectious disease and vaccination, and pediatric surgery and orthopedics. Topics include neonatal pain management, post-COVID syndrome in children, rare pediatric syndromes, childhood cancer outcomes, and parental knowledge and behavior. Manuscripts are evaluated through double-blind peer review against COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. Clinicians and investigators are invited to read current pediatric research and to submit manuscripts that improve the care and health of infants, children, and adolescents worldwide.

Advances the science and practice of clinical and medical microbiology. The journal serves microbiologists, infectious disease clinicians, laboratory scientists and public health researchers with rigorous, original scholarship that bridges the diagnostic laboratory and the bedside. We welcome original research, reviews, case reports and editorials across antimicrobial resistance (AMR) and antimicrobial stewardship, diagnostic and molecular microbiology, antimicrobial susceptibility testing, bacterial, viral, fungal and parasitic infections, healthcare-associated infections, bloodstream infections, tuberculosis, and emerging and zoonotic pathogens. Studies applying One Health, genomics, next-generation sequencing and surveillance methods are particularly encouraged. Every submission undergoes double-blind peer review in line with COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright.

Dedicated to original research that translates fundamental science into practical impact. As a multidisciplinary applied sciences journal, JOAS publishes work spanning applied physics, applied chemistry, materials and nanoscience, applied biology and life sciences, environmental and ecological science, and applied data and social science. The journal exists to connect investigators, engineers, and practitioners worldwide through a trusted and openly citable platform. JOAS welcomes original research articles, critical reviews, case reports, methodological notes, and editorials. Topics of interest include nanomaterials and energy materials such as dye-sensitised solar cells and polymer electrolytes; proteomics, immunomodulation, and biomarker studies; biodiversity, coral-reef health, soil and root-system science; instrumentation and measurement methods including SEM-EDX, X-ray diffraction, and neutron-activation standardisation; food authentication and aroma science; and applied statistical analysis of socio-economic problems such as multidimensional poverty. Every manuscript undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright. JOAS follows COPE ethical principles and offers article-processing-charge waivers and discounts to widen participation, particularly for early-career and lower-income-country authors.

Disseminates original scholarship on robot-assisted and minimally invasive surgery across the surgical specialties, serving surgeons, surgical trainees, biomedical engineers, and clinical researchers who advance the science and practice of surgical robotics. The journal covers the full arc of robotic surgery: robotic urologic surgery (including single-port and radical prostatectomy), robotic general and gastrointestinal surgery (such as distal pancreatectomy and colorectal procedures), pediatric robotic surgery (including pyeloplasty), robotic thoracic surgery, and gynecologic and hepatobiliary applications. We also welcome work on robotic platforms and the da Vinci surgical system, learning curves, operative-time and outcomes analyses, cost-effectiveness, simulation and training, and comparative laparoscopic-versus-robotic studies. We publish original research, systematic reviews, technical notes, case reports, case series, and editorials addressing the methodological, translational, and applied dimensions of the field. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. The journal follows COPE ethical principles, ensuring a citable and openly accessible scholarly record.

Most of its published papers so far examine host responses to viruses and mycobacteria — SARS-CoV-2 and post-COVID syndrome, chronic hepatitis B and C, herpesviruses and pulmonary tuberculosis — or autoimmunity, from autoantibody markers after COVID-19 and antibodies to zinc transporter 8 to vitiligo, rheumatoid arthritis and catalytic autoantibodies in experimental autoimmune encephalomyelitis. Smaller groups of JOI papers look at how immune cells are regulated, including the role of the RNA methyltransferase METTL3 in immune homeostasis, at immunomodulatory and cell-based therapies such as adipose-derived stromal vascular fraction, and at cancer treatment outcomes. The journal publishes laboratory and clinical studies, case-control genetic association studies, Mendelian randomization analyses and narrative reviews, from circulating NETosis and pyroptosis markers measured in COVID-19 patients to peptide treatment in experimental tuberculosis. Case reports are accepted when an immunological question is at their centre. Every manuscript that passes the editorial check is reviewed double-blind. JOI articles are published open access under the Creative Commons Attribution licence (CC BY 4.0), and their authors keep the copyright. The journal follows the COPE guidelines on publication ethics; an article-processing charge applies only after acceptance, with need-based waivers and discounts.

Covers the diagnostic spectrum: histopathology and surgical pathology, cytopathology and fine-needle aspiration cytology, immunohistochemistry (markers such as Her2/neu), haematopathology, clinical chemistry and biomarker studies (HbA1c, ferritin, D-dimer), and molecular and infectious-disease diagnostics using qPCR and FFPE methods. We welcome original research, reviews, diagnostic case reports, method-validation studies and editorials. Every submission undergoes double-blind peer review following COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence; authors retain copyright.

Its published work so far comes mainly from gastroenterology and hepatology, neurology, immunology, and diabetes and endocrinology, with smaller groups of papers in cardiology, surgery and orthopaedics, dentistry and maxillofacial research, and nursing and medical education. TJOCM publishes original clinical studies, narrative reviews, case reports and case series. Recent examples include a real-world evaluation of a diosmectite-based device for diarrhoea, a longitudinal multiomics study of cerebrospinal fluid in cognitive impairment, a national multicentre cohort on chronic kidney disease progression after SARS-CoV-2 infection, and a case series on myasthenia gravis. The journal is a good fit for clinicians who want to report what they observe in everyday practice — an unusual presentation, an audit of a ward population or an evaluation of a teaching method — as well as for formal observational studies. Manuscripts are assessed by double-blind peer review. Articles are published open access under a CC BY 4.0 licence, with copyright kept by the authors. The journal follows COPE ethical principles and is committed to transparency and integrity. An article-processing charge applies on acceptance, with waivers and discounts available to ensure equitable access to publication.

Advances scholarship across the breadth of the discipline and its subspecialties, including cardiometabolic medicine, nephrology, infectious and post-viral disease, geriatric medicine and frailty, and hospital and perioperative care. We publish original clinical and translational research, narrative and systematic reviews, clinical case reports and case series, and editorials that improve diagnosis, evidence-based management, and patient outcomes. Recent topics span long COVID and the gut-brain axis, frailty assessment in older adults, chronic renal disease, atherosclerosis and vascular inflammation, and postoperative outcomes after surgery. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. The journal follows COPE ethical principles and serves a global readership of internists, primary care physicians, trainees, and biomedical researchers seeking trustworthy, openly accessible internal medicine research.

Publishes original research, reviews, and case reports spanning the diagnosis, mechanisms, and management of endocrine and metabolic disease, with a translational emphasis that connects laboratory discovery to bedside practice for clinicians, endocrinologists, and biomedical researchers. Core coverage includes diabetes mellitus and incretin-based therapeutics (GLP-1 receptor agonists, tirzepatide, semaglutide), obesity and metabolic syndrome, and lipid and lipoprotein disorders such as dysbetalipoproteinemia. The journal has notable depth in adrenal disease and steroidogenesis, including congenital adrenal hyperplasia, primary adrenal insufficiency, and HPA-axis and cortisol dysregulation, alongside thyroid, pituitary, and reproductive endocrinology. We welcome studies using clinical trials, observational cohorts, endocrine diagnostics (immunoassays, imaging, ultrasonography), and emerging methods such as single-cell sequencing. Submissions are evaluated by rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons CC-BY 4.0 licence with authors retaining copyright. The journal follows COPE ethical principles.

Advances research across the full spectrum of autoimmunity and clinical immunology. The journal disseminates original scholarship on the breakdown of immune self-tolerance and the resulting systemic and organ-specific autoimmune diseases, serving immunologists, rheumatologists, clinical investigators, and translational scientists worldwide. We welcome work on systemic autoimmune rheumatic conditions such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome, alongside organ-specific disorders including autoimmune thyroiditis, vitiligo, coeliac disease, and autoimmune skin disease. Mechanistic studies of epitope spreading, autoantibodies, innate and adaptive immunity, and molecular mimicry are central to our remit, as are investigations of environmental and infectious triggers, including COVID-19, Helicobacter pylori, and drug-induced autoimmunity. The journal also prioritizes diagnosis, classification, biomarkers, epidemiology, and therapeutics, from validation of SLICC and EULAR/ACR criteria to biologic and TNF-inhibitor strategies. We publish original research, systematic reviews, case reports, and editorials. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright.

Advancing the science and clinical practice of infectious diseases. It publishes original research across infectious disease epidemiology, antimicrobial resistance and stewardship, emerging and re-emerging infections, tropical and neglected diseases, and healthcare-associated infections, serving clinicians, microbiologists, epidemiologists, and public health researchers worldwide. We welcome work across the spectrum of pathogens, including viral infections such as HIV/AIDS, hepatitis B, dengue, and Lassa fever; bacterial and fungal infections including sporotrichosis, leptospirosis, and scrub typhus; vaccine and immunization research; and clinical syndromes such as catheter-related bloodstream and post-surgical urinary tract infections. Studies on surveillance, diagnostics, antibiotic utilization (including WHO AWaRe classification), and One Health are especially encouraged. JOID accepts original research, systematic and narrative reviews, case reports, and editorials. Every submission undergoes double-blind peer review consistent with COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright.

Dedicated to advancing clinical and translational research across the musculoskeletal system. The journal disseminates rigorous original scholarship spanning orthopedic surgery, arthroplasty, sports medicine, orthopedic trauma, spine, and the biomechanics of bone, joint, tendon, and ligament, connecting surgeons, researchers, and allied practitioners through a trusted international platform. We welcome original research, systematic reviews, clinical and surgical outcome studies, case reports, technical notes, and editorials. Core topics include total knee and hip arthroplasty, ankle and ligament reconstruction, platelet-rich plasma and regenerative therapies, fracture fixation and trauma management, 3D-printed and patient-specific implants, computer-assisted navigation, gait and motion analysis, and the management of musculoskeletal tumors and degenerative disorders. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright. The journal serves orthopedic surgeons, sports-medicine physicians, biomechanists, physiotherapists, and musculoskeletal researchers worldwide. An article-processing charge applies on acceptance, with waivers and discounts available, and the journal follows COPE ethical principles throughout editorial decision-making.

Devoted to the science and clinical practice of rheumatology and musculoskeletal medicine. As an arthritis and rheumatology journal, it disseminates rigorous original research on rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis and ankylosing spondylitis, osteoarthritis, gout and crystal arthropathies, vasculitis, and other autoimmune and connective tissue diseases. The journal welcomes original research, systematic reviews, clinical trials, case reports, and editorials spanning pathophysiology, epidemiology, imaging and biomarkers, and therapeutics. Topics of particular interest include disease-modifying antirheumatic drugs and biologic therapy, early detection of inflammatory arthritis, advanced imaging such as PET-CT and musculoskeletal ultrasound, and joint-preserving and arthroplasty outcomes. Intended for rheumatologists, immunologists, orthopaedic and musculoskeletal researchers, and allied health professionals, the journal connects investigators and clinicians through a trusted, internationally accessible platform. Every submission undergoes double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. The journal follows COPE ethical principles.

Advances research, education and clinical practice on the diseases and health challenges of tropical and subtropical regions, with a strong focus on neglected tropical diseases (NTDs), malaria and vector-borne illness, tropical infectious diseases, antimicrobial resistance, and public health and nutrition in low- and middle-income settings. We publish original research, systematic and narrative reviews, case reports and case series, short communications and editorials spanning clinical tropical medicine, parasitology and entomology, bacteriology, mycology and virology, infectious-disease epidemiology, One Health approaches to antimicrobial resistance, and outbreak and elimination science. Topics range from malaria burden and schistosomiasis to HIV-associated opportunistic infections, COVID-19 endemic transition, antibiotic residues in hospital wastewater, and child malnutrition across Africa. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright. ATM follows COPE ethical principles and especially welcomes evidence-based work from researchers and clinicians in endemic regions, offering article-processing-charge waivers and discounts to support global, equitable participation in the scholarly record.

Disseminates original research, reviews, case studies, and short communications across the environmental sciences, with emphasis on environmental pollution and control, wastewater and nutrient treatment, air quality, climate change, greenhouse-gas and carbon accounting, renewable energy, and sustainability. The journal welcomes work spanning environmental monitoring and remote sensing (drought indices such as VCI and VHI, satellite rainfall products, and LiDAR-based biomass and carbon-stock estimation), water and soil conservation, ecology and biodiversity, circular-economy waste management, and environmental nanomaterials and toxicity. We value rigorous field, laboratory, modeling, and policy-analysis methods that advance both fundamental understanding and applied environmental management. JOES serves environmental scientists, engineers, ecologists, policy analysts, and practitioners worldwide. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright. The journal follows COPE ethical principles, and an article-processing charge applies on acceptance, with waivers and discounts available for eligible authors.

Advances clinical and translational scholarship across the breadth of oral health science, serving dentists, oral and maxillofacial surgeons, periodontists, endodontists, prosthodontists, pediatric and public-health dental clinicians, and biomedical researchers worldwide. The journal welcomes original research, clinical trials, in vitro and laboratory studies, systematic reviews, narrative reviews, case reports, and short communications. Core areas include implant dentistry and osseointegration (implant stability, osseodensification, alveolar ridge preservation, abutment design), oral and maxillofacial surgery and tissue regeneration (platelet-rich fibrin, bone regeneration, sinus anatomy), restorative dentistry, endodontics and dental pulp biology (odontogenic differentiation, biomaterials, dental erosion), and pediatric and preventive dentistry (silver diamine fluoride, caries control, oral health education). JODOR also features emerging themes in digital and public-health dentistry, including artificial intelligence in dental education, genomic dentistry, oral health epidemiology, and access to care. The journal emphasizes methodological rigor, biocompatibility, and clinical effectiveness. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright. The journal follows COPE ethical principles.

Its published papers so far fall into three groups: treatment studies, forensic psychiatry in young people who are in contact with the justice system, and community and social psychiatry. The treatment studies cover two real-world studies of Passiflora incarnata extract and a critical review of psychedelic-assisted psychotherapy, MDMA included, for post-traumatic stress disorder in Brazil, while the community papers range from late-life depression to the stigma felt by people with obsessive-compulsive disorder. JOPR publishes original clinical and community studies, case series and reviews. Examples include a psychometric re-study of the eight-item CES-D depression scale in newly arrested youth, a case series of young violent offenders with autism spectrum disorder, a community-based cross-sectional survey of depression in 825 older adults in Gondar, Ethiopia, an online survey of internalised stigma in 83 people with OCD, and a prospective real-world study of 112 patients with irritable bowel syndrome and mild anxiety. JOPR manuscripts are assessed double-blind, so authors and their reviewers stay anonymous to one another. Accepted papers appear open access under CC BY 4.0, the Creative Commons Attribution licence, and the copyright stays with the people who wrote them. Editorial practice follows the COPE guidelines, and the article-processing charge is billed only once a paper is accepted, with waivers and discounts for authors who lack funding.